The effect of oral administration of 0.08% 4-aminoazobenzene (AB), 0.09% 3-methoxy-4-aminoazobenzene (3-MeO-AB), 0.1% 3, 4'-dimethoxy-4-aminoazobenzene (3, 4'-(MeO)
2-AB), 0.09% 4-monomethyl- and 4-(dimethylamino)azobenzene (MAB and DAB) in the diet was studied in Donryu male rats with special reference to their carcinogenicity, target organs, as well as the histopathology of the induced tumors.
1) AB did not cause any cancerous change in any organs excepting in one rat in which a fibrosarcomatous nodule, covered by the omentum and mesenterium, was found.
2) MAB and DAB produced tumors in the liver alone. Histologically, these were poorly differentiated hepatocarcinoma and transitional type between hepato- and cholangio-cellular carcinoma.
3) 3-MeO-AB produced well-differentiated hepatocarcinoma, malignant hemangiopericytoma of the spleen, and squamous cell carcinoma of the ear duct in 21(91%), 6(26%), and 2(8%), respectively, out of 23 rats.
4) 3, 4'-(MeO)
2-AB developed well-differentiated hepatocarcinoma, squamous cell carcinoma of the ear duct, and tubulary adenocarcinoma of the small intestine in 24(100%), 1(4%), and 2(8%), respectively, out of 24 rats.
5) The average time for tumor development was shorter in MAB and DAB groups than in 3-MeO- and 3, 4'-(MeO)
2-AB groups.
View full abstract